Ubs Asset Management Americas Inc Applied Therapeutics Inc. Call Options Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.02 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$3.95 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$3.63 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$2.73 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.3 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $16.8M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...